SCHEMBL13487601

SCHEMBL13487601

CC1(C)c2ccccc2-c2cc(-c3c4ccccc4c(-c4cnccn4)c4ccc(-c5cccc6ccccc56)cc34)ccc21

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5AP P20292 2/20 0.34
FEN1 P39748 2/20 0.34
TNF P01375 1/20 0.33
HTR2C P28335 1/20 0.32
MAPT P10636 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
CCNT1 O60563 1/20 0.32
CCNA2 P20248 1/20 0.32
CDK2 P24941 1/20 0.32
CDK9 P50750 1/20 0.32
GSK3B P49841 2/20 0.32
ENPP3 O14638 1/20 0.32
ENPP1 P22413 1/20 0.32
CDK5 Q00535 1/20 0.32
CDK5R1 Q15078 1/20 0.32
BACE1 P56817 1/20 0.32
KDM4E B2RXH2 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TLR8 Q9NR97 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13487982 0.95 ALOX5AP (0.36) ALOX5APFEN1TNFHTR2CMAPT
SCHEMBL13487686 0.90 CYP11B1 (0.36) ALOX5APFEN1KDM4EPIM1
SCHEMBL13487594 0.90 HTR2C (0.41) HTR2CMAPTCCNT1CCNA2CDK2
SCHEMBL13487754 0.90 ALOX5AP (0.36) ALOX5APFEN1SLC6A2SLC6A4SLC6A3
SCHEMBL13487176 0.89 ALOX5AP (0.34) ALOX5APFEN1TNFHTR2CMAPT
SCHEMBL13487516 0.89 PDK2 (0.35) ALOX5APFEN1BACE1PIM1
SCHEMBL13487605 0.88 CCNT1 (0.33) TNFHTR2CMAPTCCNT1CCNA2
SCHEMBL13487448 0.87 ALOX5AP (0.34) ALOX5APFEN1MAPTMEN1KMT2A
SCHEMBL13487603 0.87 KDM4E (0.41) TNFMAPTMEN1KMT2ABACE1
SCHEMBL13488127 0.87 ALOX5AP (0.38) ALOX5APFEN1SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same GRACEL DISPLAY INC. (KR) 2010-02-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100045170-A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same OCIAD1, OCIAD2, ORMDL3 ALOX5AP 230/4885FEN1 1389/4885TNF 1949/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.